2311-2318
Design, Synthesis, Characterization and Antiproliferative Activities of Ru(II) Complexes of Substituted Benzimidazoles
Authors: Ashok K. Singh, Snehlata Katheria , Amrendra Kumar, Asiff Zafri and Mohd. Arshad
Number of views: 156
Synthesis of [Ru(PPh3)2(BZM)2Cl2] (BZM= LS1, LS2, LS3, LS4 and LS5) where
LS1=(1H-benzo[d]imidazole-2-yl)methanethiol, LS2 = 2-(4-bromobutyl)-1H-benzo[d]imidazole, LS3
= 2-(4-nitrophenyl)-1H-benzo[d]imidazole, LS4 = 2-(4-chlorophenyl)-1H-benzo[d]imidazole and
LS5= 4-(1H-benzo[d]imidazol-2-yl)aniline (BZM = benzimidazoles, PPh3 = triphenylphosphine) and
metal complexes as MR, [ Ru (PPh3)4Cl2], MLS1, MLS2, MLS3, MLS4 and MLS5 for use as potential
anticancer compounds have been investigated. The complexes have been characterized by elemental
analysis, IR, multinuclear NMR, UV-visible and ESI-MS spectroscopic techniques. The geometries
of all complexes have been optimized by using density functional theory (DFT). The cytotoxicity
effects of MR, MLS2 and LS1 were also investigated on Human cervical carcinoma cells (HeLa) by
MTT assay, ROS generation and nuclear apoptosis assay. The percent cell viability assessed by MTT
assay suggested that the synthesized MR, MLS2 and LS1 significantly reduce the viability of HeLa
cells, in a dose-dependent manner. The inhibitory concentration (IC50) of MR, MLS2 and LS1 against
HeLa cells was found 90.8, 81.8 and 115 μM, respectively. These compounds also induced the over
production of intracellular reactive oxygen species (ROS) as well as the condensed and fragmented
nucleus, which supports the molecular mechanism of cell death by apoptosis. The investigations
suggested that the compounds MR, MLS2 and LS1 induce the cell death in HeLa cells through apoptotic
pathway.